Antimicrobial and antibiofilm potential of injectable platelet rich fibrin—a second-generation platelet concentrate—against biofilm producing oral staphylococcus isolates

• Published in: Saudi journal of biological sciences 2020-01, Vol.27 (1), p.41-46
• Main Authors: Jasmine, Sharmila, A., Thangavelu, Janarthanan, K., Krishnamoorthy, Rajapandiyan, Alshatwi, Ali A.
• Format: Article
• Language: English
• Subjects: Antibiofilm; Antimicrobial peptides; Injectable platelet rich fibrin; Oral pathogen; Second generation platelet concentrates; الأغشية الحيوية; المضادات الحيوية; المكورات العنقودية; صفائح الدم
• ISSN: 1319-562X; 2213-7106
• DOI: 10.1016/j.sjbs.2019.04.012

Injectable Platelet rich fibrin (i-PRF) is a platelet concentrate that has been extensively used for multiple medical purposes and is a valuable adjunct for the regeneration of damaged tissues in surgical procedures. The enriched bioactive substances in i-PRF are responsible for speeding the wound healing process. Infection of biofilm producing bacteria in surgical wounds is becoming a serious threat. Research in this field is focused on new strategies to fight infections and to reduce the healing time. The present study was aimed to evaluate the in vitro antimicrobial and antibiofilm effects of i-PRF against oral pathogenic biofilm producing staphylococcus bacteria isolated from patient with dental and oral abscess. The antibacterial activity of i-PRF, was determined through broth microdilution as minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC). i-PRF exhibited bactericidal activity against both non biofilm and biofilm producing bacteria. i-PRF could be potential antimicrobial peptide used to combat postoperative infections caused by biofilm producing staphylococcus.